Cytecom's Rapid Detection Technology

Learn more about the groundbreaking technology enabling our vision for a new, rapid diagnostic.

How our Technology Works

Our CTO, Dr. James Stratford, will introduce the fundamentals of our technology

Antimicrobial Susceptibility Testing

Our Application Scientist, Noah Tattersall, will demonstrate the efficacy of Ampicillin antibiotic on E. coli populations, using our initial platform, the CyteCount

Checkout our Research

Press the button above to read the research that led to the creation of Cytecom.